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The placenta is the exchange organ that regulates metabolic processes between the
mother and her developing fetus. The adequate function of this organ is clearly vital for a
physiologic gestational process and a healthy baby as ﬁnal outcome.The umbilico-placental
vasculature has the capacity to respond to variations in thematerno-fetal milieu. Depending
on the intensity and the extensity of the insult, these responses may be immediate-,
mediate-, and long-lasting, deriving in potential morphostructural and functional changes
later in life. These adjustments usually compensate the initial insults, but occasionally
may switch to long-lasting remodeling and dysfunctional processes, arising maladaptation.
One of the most challenging conditions in modern perinatology is hypoxia and oxidative
stress during development, both disorders occurring in high-altitude and in low-altitude
placental insufﬁciency. Hypoxia and oxidative stress may induce endothelial dysfunction
and thus, reduction in the perfusion of the placenta and restriction in the fetal growth
and development. This Review will focus on placental responses to hypoxic conditions,
usually related with high-altitude and placental insufﬁciency, deriving in oxidative stress
and vascular disorders, altering fetal and maternal health. Although day-to-day clinical
practice, basic and clinical research are clearly providing evidence of the severe impact of
oxygen deﬁciency and oxidative stress establishment during pregnancy, further research
on umbilical and placental vascular function under these conditions is badly needed to
clarify the myriad of questions still unsettled.
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INTRODUCTION
The placenta is the exchange organ between the pregnant woman
and her developing fetus. The adequate function of this organ is
clearly essential for a proper progress of gestation and a healthy
baby as ﬁnal outcome. As every developing organ, the pla-
centa has an adapting capacity to variations in materno-fetal
conditions, with short and long-lasting responses deriving in
potential morphostructural and functional changes. These adjust-
ments sometimes compensate the initial triggering insults and
Abbreviations: 4HNE, 4-Hydroxynonenal; ADMA, asymmetric dimethylarginine;
ANGPT, angiopoietins; BH4, tetrahydrobiopterin; CO, carbon monoxide; DOHaD,
developmental origins of health and disease; eNOS, endothelial nitric oxide syn-
thase; EPO, erythropoietin; ET-1, endothelin-1; GPx, glutathione peroxidase;
H2O2, hydrogen peroxide; HO, heme oxygenase; HIF, hypoxia-inducible factor;
HSP70, heat-shock protein 70; IGF, insulin-like growth factor; IUGR, intrauter-
ine growth restriction; K(V), voltage-gated potassium channel; K+, potassium;
NADPH, nicotinamide adenine dinucleotide phosphate; NF-κB, nuclear factor kap-
paB; NO, nitric oxide; O2, oxygen; •O2−, superoxide anion; •OH−, hydroxyl
radical; PDGFB, platelet-derived growth factor subunit B; PE, preeclampsia; ROS,
reactive oxygen species; SGA, small for gestational age fetus; SOD, superoxide dis-
mutase; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor;
XD, xanthine dehydrogenase; XO, xanthine oxidase.
occasionally may switch to long-lasting remodeling processes
arisingmaladaptation, affecting its own function and thematerno-
fetal health. Appropriate levels of oxygen and reactive oxygen
species are determinants in placental development and function.
This review will focus on placental responses to hypoxic envi-
ronments, usually associated with oxidative stress and vascular
functional impairments.
HYPOXIC CONDITIONS DURING DEVELOPMENT
One of the most challenging conditions in modern peri-
natology is hypoxia during development. This is consid-
ered harmful to the fetus due to the short- and long-
term devastating effects, particularly in the central nervous
and cardiovascular systems, resulting in functional alterations.
Furthermore, in utero adverse conditions can increase the
risk of developing chronic diseases later in life, phenom-
ena known as fetal programming or developmental origins
of health and disease-DOHaD (Fowden and Forhead, 2009;
Gunn and Bennet, 2009; Li et al., 2012). However, less focus
has been put on the placenta and its protective role during
development.
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Hypoxia is deﬁned as a deﬁcient oxygen (O2) supply for the
physiological demands of a tissue. This is a restrictive condition
frequently faced during fetal life, either by maternal or umbilico-
placental circumstances, or by environmental hypoxia as seen in
highlands.
Nowadays, it is estimated that worldwide there are 150 mil-
lion newborns per year and 5–10% of them will have low birth
weight standardized for gestational age (Alberry and Soothill,
2007; Nardozza et al., 2012). Placental insufﬁciency leads to fetal
growth restriction (IUGR) due to a decreased feto-placental
perfusion and restricted oxygen delivery. This situation affects
simultaneously O2 and nutrient supply to the fetus (Baschat,
2011), overlapping conditions that difﬁcult the isolation of the
speciﬁc effects of O2 deﬁciency in the determination of vas-
cular impairment. Conversely, altitude decreases environmental
pressure and consequently, alveolar PO2, deriving in high alti-
tude hypoxia (Niermeyer et al., 2009). There is no precise data
about the number and complications in high altitude pregnancies,
but hypoxia-related problems during gestation are dramatically
increased above 2500 m (Keyes et al., 2003; Moore et al., 2004;
Zamudio, 2007; Julian, 2011). Currently, it is estimated that more
than 150 million people live in highlands worldwide (Niermeyer
et al., 2009). Of those, 35 million live in the Andean Mountains,
in important cities, such as La Paz, capital of Bolivia (Keyes
et al., 2003). This has led to an increased clinical and scientiﬁc
interest in dissecting the different noxas that induce fetal program-
ming (Luo et al., 2006; Franco et al., 2007; Nuyt, 2008; Schleithoff
et al., 2012), but few have focus on the lack of oxygen as a main
cause.
HYPOXIA AND OXIDATIVE STRESS
One of the mechanisms by which hypoxia induces damage is as
a result of the increased generation of reactive oxygen species
(ROS) by an incomplete reduction of oxygen (Abramov et al.,
2007; Giussani et al., 2012; Pialoux and Mounier, 2012). ROS
are free radicals produced as by-products of oxidation–reduction
reactions. There are various intracellular enzymatic pathways
that produce ROS in mammals, such as mitochondrial electron
transport, NADPH oxidase, the cytochrome P450 monoxygenase
system, xanthine oxidase, nitric oxide synthases, cyclooxyge-
nase, and lipoxygenase (Apel and Hirt, 2004; Dowling and
Simmons, 2009). Particularly in the vasculature, the main sources
of superoxide anion (•O2-) areNADPHoxidase, xanthine oxidase,
uncoupled endothelial nitric oxide synthase (eNOS) and mito-
chondria (Katusic, 1996; Förstermann and Sessa, 2012). Relatively
low concentrations of ROS are necessary to operate as signaling
molecules in thenormal regulationof cell differentiation and func-
tion. However, the increased ROS generation may overwhelm the
antioxidant endogenous capacity and determine oxidative stress
(Figure 1). For instance, it has been established in several experi-
mental models that ischemia/reperfusion, hypoxia/reoxygenation
and even hypoxia itself can promote oxidative stress (Comhair and
Erzurum, 2002; Guzy and Schumacker, 2006; Waypa et al., 2006;
Behn et al., 2007; Clanton, 2007; Ward, 2007; Loor et al., 2011;
Sylvester et al., 2012).
An important source of ROS is the mitochondrial electrons
chain. At physiological oxygen levels, it has been suggested that
FIGURE 1 |Vascular responses induced by hypoxia and oxidative
stress. Hypoxia may increase ROS generation and induce (activate)
transcription factors such as HIFs and NFκB. Consequently, the
transcription of several genes is activated, inducing vasoconstriction and
vascular remodeling. In addition, hypoxia and oxidative stress may induce
endothelial dysfunction. All of the above impair vasodilatation capacity in
the umbilico-placental vasculature and increases the risk of IUGR and
miscarriage. ROS,: reactive oxygen species; HIFs, hypoxia inducible
factors;, NFκB, nuclear factor-kappa B.
about 1–4%of theO2 reducedbymitochondriamay form •O2- (Li
and Shah, 2004). However, under conditions of metabolic pertur-
bation such as hypoxia/reoxygenation (Pearlstein et al., 2002), the
percentage of oxygen incompletely reduced can increase, promot-
ing enhanced production of ROS by the mitochondria (Sanjuan-
Pla et al., 2005; Guzy and Schumacker, 2006; Loor et al., 2011).
Thus, studies have shown that a functional respiratory chain is
required and that loss of cytochrome c (complex III), abolishes this
ROS signal (Guzy et al., 2005; Guzy and Schumacker, 2006). Out-
standingly, the direct additionof ROS such asH2O2 overcomes this
blockade (Bell et al., 2007). These studies have led to the proposal
that mitochondrial complex III is one of the main sources of ROS
(Guzy and Schumacker, 2006).
In addition to ROS generated as a “byproduct” of cellular
respiration, endogenous production of •O2- also arises from
NADPH oxidases (NOX 1, 2, 4, and 5) normally at low lev-
els in smooth muscle and vascular endothelium (van der Vliet,
2008; Rivera et al., 2010). Another source of ROS is cytochrome
P450, an enzyme involved in the metabolism of arachidonic
acid in the vascular endothelium (Fleming et al., 2001). Super-
oxide anion and hydroxyl radical (•OH-) are produced during
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the cytochrome P450 reaction cycle when the electrons for the
reduction of the central heme iron are transferred to the acti-
vated bound O2 molecule in an NADPH-dependent reaction
(Fleming, 2001). Another important source of ROS is xanthine
oxidase (XO), a metalloﬂavoprotein which is generated by the
post-translational modiﬁcation of xanthine dehydrogenase (XD)
(Hewinson et al., 2004). Functionally, both XD and XO catalyze
oxidation of hypoxanthine to xanthine and xanthine to uric acid,
with the generation of •O2- (Zhang et al., 1998; Meneshian and
Bulkley, 2002). Endothelial nitric oxide synthase (eNOS) may also
act as a generator of ROS and is dependent on NOS substrates and
cofactors. Endothelial nitric oxide synthase is a calcium-dependent
ﬂavoenzyme that generates NO in a process that involves oxi-
dation of the amino acid L-arginine via the reduction of O2
(Cai and Harrison, 2000). Intracellular calcium levels control the
eNOS-calmodulin association which is an important stage in the
activation of eNOS (Stuehr, 1999). Another protein which can
control eNOS activity is heat shock protein 90 (HSP90), a molecu-
lar chaperone that increases eNOS activity, possibly by increasing
the rate of electron transfer between the two domains of eNOS
(Stuehr, 1999). The process of NO production also requires the
essential NOS cofactor tetrahydrobiopterin (BH4) as it plays a
crucial role in coupling the reduction of O2 to the oxidation
of L-arginine as well as maintaining the stability of the NOS
dimers (Vasquez-Vivar et al., 2003). If the production or efﬁ-
ciency of BH4 decreases, or if there is a deﬁciency in the NOS
substrate L-arginine, then NOS can become uncoupled result-
ing in the production of •O2- instead of NO (Lei et al., 2013;
Figure 1).
VASCULAR EFFECTS
Most studies onumbilico-placental vascular function areDoppler-
based, therefore non-invasive and mostly present descriptive
analysis. Nonetheless, ex vivo experimental approaches, such as
vascular myography and placenta perfusion, have offered impor-
tant clues of mechanisms modulating umbilico-placental vascular
function in diverse perinatal conditions.
Vascular tone regulation
Vascular tone is dependent on the balance between vasodilator
and vasoconstrictive agents. The endothelial-independent NO-
induced vascular relaxation has been assessed in normal term
placentas (Myatt, 1992; Wareing et al., 2005), and correlates
inversely to Doppler pulsatility and resistance indexes (Wareing
et al., 2005). Otherwise, in complicated pregnancies with fetal
growth restriction umbilical artery pulsatility index inversely cor-
relates with placental eNOSmRNA levels (Giannubilo et al., 2008).
In addition, arginase, an endogenous negative regulator of eNOS
which counteracts the NOS-dependent relaxation in umbilico-
placental vessels (Krause et al., 2012), is increased by hypoxia in
umbilical vein endothelium (Prieto et al., 2011) and in plasma
from pre-eclamptic women (Sankaralingam et al., 2010). Fur-
thermore, arginase inhibition restores the impaired NOS-induced
relaxation in IUGR umbilical and chorionic arteries (Krause et al.,
2013). Another vasodilator suggested to be involved in placen-
tal vasodilation is carbon monoxide (CO), which is decreased in
preeclampsia and IUGR (Barber et al., 2001). In compensating CO
andNOdysfunction in complicated pregnancies, an up-regulation
of H2S has been shown to vasodilate the placental vasculature
via potassium channels (Cindrova-Davies et al., 2013). Similar to
other oxygen-sensitive vasculature, potassium channels are main
determinants of vascular resistance (Wareing and Greenwood,
2011) and vasculogenesis (Brereton et al., 2013) in chorionic plate
vessels. Previous studies have not been conclusive for the role of
these channels in complicated pregnancies, but some authors sug-
gests that K(V) may be involved in IUGR (Corcoran et al., 2008)
and ROS might be regulating their function in the placenta (Mills
et al., 2009), elevating vascular resistance. Furthermore, it has been
shown that ROS enhanced basal tension and vasoconstriction in
response to a thromboxane mimetic (Mills et al., 2009). Although
the exactmechanism is unknown,K+ channelsmay be involved in
maintaining a lower membrane potential, and therefore depolar-
ization processes are easy to be activated and induce contraction.
However, ROS may as well increase relaxation in response to NO
(Mills et al., 2009).
The responses in placental vascular tone to different levels of
oxygenation are still under debate and extensively reviewed by
Wareing (2014). Some argue similar effects as those observed in
the pulmonary bed, where oxygenation promotes vasodilation
and others suggest a vasoconstriction response in umbilico-
placental veins (Wareing, 2014). Even more, some authors
sustain that vascular reactivity in chorionic arteries is inde-
pendent of oxygen levels (Cooper et al., 2005; Wareing et al.,
2006). The differences found might be dependent on the exper-
imental conditions and the oxygenation levels, where much
of these are made under relatively hyperoxic conditions when
compared to the ranges of ∼15–30 mmHg in vivo PO2 (Ware-
ing, 2014). Furthermore, there is a differential response in
the ex vivo experiments depending on the mode of deliv-
ery (Mills et al., 2007). Clearly the debate is open, and the
responses in hypoxic pathological conditions cannot be pre-
dicted. Despite their fundamental importance for normal per-
fusion of the placenta, still the umbilico-placental vascular
reactivity has been poorly studied, particularly in pathological
conditions.
Vascular protein expression
The vascular effects on gene expression and cellular responses to
hypoxia andoxidative stress are alike, sharing similar effector path-
ways. For instance, both conditions activate the hypoxia-inducible
factor (HIF-1) and therefore induce several proteins associated
with remodeling processes. It has been proposed that mitochon-
dria are O2 sensors and signal HIF-1α stabilization by releasing
ROS to the cytoplasm (Simon, 2006). HIF-1 is a transcription fac-
tor that is activated under hypoxia (Semenza and Wang, 1992)
and regulates over 100 physiologically important genes that may
affect the vascular function (Semenza, 2006). HIF-1α is in fact
regulating the transcription of many vascular remodeling related
genes (Yu et al., 1999; Schoﬁeld and Ratcliffe, 2004; Semenza,
2006), leading to increased tone, thickening and stiffening of the
vasculature. Increases in HIF-1 and HIF-2 activity induce pro-
duction of angiogenic growth factors and cytokines in hypoxic
cells, such as VEGF, EPO, ANGPT, and PDGFB (Prabhakar and
Semenza, 2012). All of these will induce vascular smooth muscle
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cell proliferation and a balanced tone towards increased resis-
tance under chronic hypoxia (Prabhakar and Semenza, 2012). In
addition, HIFs also play a more general role in the response to
a variety of cellular activators and stressors, many of which use
ROS as signal transducers (Cash et al., 2007; Görlach and Kiet-
zmann, 2007). Although HIF-1 and HIF-2 may upregulate the
expression of pro-angiogenic factors, the ﬁrst tend to diminish the
inﬂammatory response, whereas the second increases the response
(Loboda et al., 2012). Therefore, in endothelial cells, both factors
may have opposite effects, probably a ﬁne tuning depending on
the oxygen or ROS levels. HIF-3 is a third isoform, which has
been less studied but postulated to act as a negative regulator of
HIF-mediated transcription (Loboda et al., 2012). Currently, the
most studied andwithmore ascribable roles in vascular expression
responses if HIF-1. HIF-1α is increased in high-altitude placen-
tas (Soleymanlou et al., 2005; Zamudio et al., 2007) and has an
important role in lowland preeclampsia (Tal, 2012; Akhilesh et al.,
2013), such as it has been proposed as a predictive biomarker
of late pre-eclampsia (Akhilesh et al., 2013). A recent discussion
has proposed that preeclampsia does not lead to hypoxia as has
been presumed (Huppertz et al., 2014). In fact, Huppertz et al.
(2014) cited three papers where the calculated PO2 seems to be
higher in patients with preeclampsia and/or IUGR. However, no
in vivo measurements have been ever done in uterine or pla-
cental tissue in complicated pregnancies, so the debate is still
open.
Another transcription factor that is activated by hypoxia and
oxidative stress is the nuclear factor kappaB (NF-κB) (Haddad,
2004). Although this factor is more related to innate immunity,
inﬂammation, and apoptosis, it regulates genes that induce remod-
eling processes (Ungvari et al., 2006; Taylor and Cummins, 2009).
Thus, NF-κB is involved in angiogenesis of the placenta (Min
et al., 2003; Chen et al., 2008). The immune and inﬂammatory
responses induced by NF-κB activation initiates and accelerates
vascular remodeling, vascular inﬂammation, endothelium apop-
tosis, vascular oxidative stress and impaired NO bioavailability
(Gao et al., 2008), which contribute to the blunted vascular func-
tion (Foncea et al., 2000; Csiszar et al., 2008). Furthermore, NF-κB
may induce tumor necrosis factor-α (TNF-α), which plays a piv-
otal role in endothelial dysfunction (Gao et al., 2008; Zhang,
2008). It seems that NF-κB-induced local inﬂammatory reaction
may have important placental dysfunctional features, at least in
pre-eclampsia (Guedes-Martins et al., 2013). Recent studies have
demonstrated that similar oxygen-sensing mechanisms, such as
hydroxylases, are determinants on oxygen sensitivity for both HIF
and NF-κB-dependent gene expression. Furthermore, there is an
extensive degree of cross-talk occurring between NF-κB and HIF
(Taylor and Cummins, 2009; Scholz and Taylor, 2013). Therefore,
hypoxia and oxidative stress are activating transcription signal-
ing pathways that may end in placental vascular dysfunctions
(Figure 1).
HYPOXIA, UMBILICO-PLACENTAL DEFICIENCIES, AND IUGR
Hypoxia and oxidative stress levels in the placenta change along
gestation. At initial stages of development, there is a reduced
utero-placental vasculature and therefore, a low perfused and
oxygenated environment. This hypoxic condition seems to be
protective for the placenta and fetus as it is exposed to less
oxygen radicals (Jauniaux et al., 2006). However, after trophoblas-
tic invasion and placental development, the fetus and placenta
demands for oxygen increases, and are covered by maternal
blood supply in the intervillous space (Jauniaux et al., 2006;
Schneider, 2011; Murray, 2012). In contrast, placental growth
reaches its limits at term and terminal villi become over-crowded
with diminished intervillous pore size. This physiologic con-
dition will decrease the intervillous perfusion generating local
hypoxia and oxidative stress (Schneider, 2011; Redman et al.,
2014). Therefore, in the placental function, there is more chance
of hypoxia and oxidative stress near delivery (Figure 2). Environ-
mental hypoxic conditions or maternal problems that decrease
PO2 may anticipate this physiological response to hypoxia in
the placental unit. This condition is particularly important in
the last trimester of gestation, when overlapping situations as
placental and fetal energy demands are dramatically increased
and the feto-placental unit respond in order to optimize the
allocation of oxygen between competing demands (Schneider,
2011; Murray, 2012). As oxygen is a vital regulator of pla-
cental and fetal development (Genbacev et al., 1997; Zamudio
et al., 2007), these responses are adaptive for fetal survival
with evident restrictions in their demands, as seen in IUGR
fetuses (Burton and Jauniaux, 2004; Soleymanlou et al., 2005;
Soria et al., 2013).
Reduced fetal growth is well documented under the conditions
of chronic hypoxia at high altitude (Keyes et al., 2003; Moore et al.,
2004; Zamudio, 2007; Julian, 2011; Soria et al., 2013). In human
high-altitude placentas, there are increased nitrotyrosine residues
in the syncytiotrophoblast, nitrative stress and lower concentra-
tions of anti-oxidants (Zamudio et al., 2007). These results show
that hypoxia is inducing oxidative stress in placentas (Bosco et al.,
2012). This is also observed inplacentae from lowlandwomenwith
pre-eclampsia and IUGR (Myatt et al., 2000). Further, maternal
exposure to an equivalent level of chronic hypoxia in a rat model,
signiﬁcantly elevate maternal and placental molecular indices of
oxidative stress, such as HSP70 and 4HNE (Richter et al., 2012).
However, placentas at 3100 m do not increase total oxidative stress
at delivery (Zamudio et al., 2007; Tissot van Patot et al., 2010). This
was suggested to be a hypoxic preconditioning response thatmight
occur in placentas that develop at high altitude (Tissot van Patot
et al., 2010). The differences found in the placental level of oxida-
tive stress might depend on the species, the period of exposure
to hypoxia, the severity of the insult and the genetic background
of the individual (Jauniaux et al., 2006; Richter et al., 2009, 2012;
Tissot van Patot et al., 2010).
Another condition where placenta dysfunction and oxidative
stress are directly involved is pre-eclampsia. Pre-eclampsia is a
multi-system disorder characterized by high blood pressure and
proteinuria in pregnant woman (Sibai, 2005). Although, no clear
cause is known to induce this pathology, several proposals point
toward an inadequate placentation andplacental dysfunction (Jau-
niaux et al., 2006; Redman et al., 2014). Interestingly, high-altitude
populations have increased incidence of pre-eclampsia (Escudero
and Calle, 2006; Zamudio, 2007; Julian, 2011; Gonzales, 2012).
In fact, this has been replicated in gestational hypoxia inducing
preeclamptic-like symptoms in pregnant rats (Zhou et al., 2013).
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FIGURE 2 | Theoretical depiction proposing the correlation of
ROS, PO2 and development of the placenta and the fetus. The
intrauterine (utero-placental) ROS formation is a function of PO2 in
which, hypoxia supports elevations in ROS. Furthermore, the
placental and fetal weights are closely related and dependent on
increases in PO2 and limitation of ROS. Changes in any of the
four variables, may directly affect the potential maximum amount of
the rest of the variables. For instance, a decrease in PO2 may
diminish fetal growth and term weight (IUGR). ROS, reactive oxygen
species.
Furthermore, hypoxic stabilization of HIF-1α seems to have an
important role in pre-eclampsia pathogenesis (Tal, 2012). Similar
as in hypoxic conditions, pre-eclamptic placentas show increased
oxidative stress (Vaughan and Walsh, 2012; Redman et al., 2014),
potentially contributing to the impairment of placental perfusion
by affecting vascular function (Myatt et al., 2000; Richter et al.,
2009; Bosco et al., 2012). In pre-eclampsia there is a failure in
trophoblast invasion and insufﬁcient modiﬁcation of spiral arter-
ies, which has been described to lead, although not necessarily, to
placental hypoxia (Huppertz et al., 2014). In addition to the func-
tional impairment, the placental vascular bed is greatly reduced in
chronic fetal hypoxia (Kuzmina et al., 2005; Sankar et al., 2013).
The mechanisms involved will not only impact fetal life, but will
have mediate- and long-lasting effects in the newborn (Gheorghe
et al., 2007; Fowden and Forhead, 2009; Gunn and Bennet, 2009; Li
et al., 2012; Giussani et al., 2012). The programming effects on the
feto-placental unit due to intrauterine stress such as hypoxia and
the potential mechanisms are currently intensively under research.
The proposed main modulating mechanisms are epigenenetic,
such as DNA methylation and histone deacetylation, reviewed in
this issue by Casanello et al. (2014).
Clearly, the placental and fetal developments are dependent on
oxygen availability and ROS restraint. Moreover, the levels of oxy-
gen and ROS are as well dependent on placental function, creating
interdependence among these variables and fetal development and
growth (Figure 2).
CLINICAL EVIDENCE
The combination of fetal biometry andmaternal and fetal Doppler
provides the best clinical approach, which are complementary
to each other to identify small for gestational age fetuses (SGA)
as well as those with intrauterine growth restriction (IUGR) at
risk of adverse outcomes due to placental insufﬁciency (Figueras
and Gardosi, 2011; Parra-Saavedra et al., 2014). Although the pre-
cise mechanisms by which placental function is affected remain
unknown, there may possibly be a primary defect in placental
development as the underlying abnormality. For the vast majority
of the IUGR cases, the underlying defect is due to poor trophoblas-
tic invasion of maternal spiral arteries and reduced uteroplacental
ﬂow (Brosens et al., 2011; Everett and Lees, 2012). When oxy-
gen delivery to the fetus falls below a critical value, fetal oxygen
uptake and glucose transfer are reduced and fetal hypoglycemia
leads to gluconeogenesis from hepatic glycogen stores (Econo-
mides and Nicolaides, 1989; Nicolini et al., 1989). There is a
down-regulation of active placental transport, independent of
the presence of hypoxia or the severity of the IUGR and the
fetus needs to mobilize other energy sources, resulting in more
widespread metabolic changes such as alteration of amino acid
metabolism and transport across the placenta (Cetin and Alvino,
2009; Avagliano et al., 2012). Maternal metabolic signals (lep-
tin, insulin, and adiponectin plasma levels) lead to placental
regulation of nutrient transport to the fetus (Lager and Powell,
2012) An increasing degrees of fetal metabolic compromise has
been documented by cordocentesis in human fetuses showing
that some SGA fetuses are hypoxemic, hypercapnic, hyperlac-
ticemic, acidemic, and hypoaminoacidemic (Cetin and Alvino,
2009; Avagliano et al., 2012). In umbilical venous blood, mild
hypoxemia may be present in the absence of hypercapnia or
acidemia. However, in severe utero-placental insufﬁciency the
fetus cannot compensate hemodynamically and thus, hypercap-
nia and acidemia increase exponentially. The immediate effect
of decreased fetal glucose and amino acids levels is the down-
regulation of the principal endocrine growth axis involving
insulin, IGF I, IGF II and transforming growth factor beta adding
negative impact on fetal growth (Randhawa, 2008; Lager and
Powell, 2012).
The endothelial regulation of umbilico-placental vascular tone
may be abnormal in pregnancies complicated by IUGR. Although
the mechanisms may be diverse in the vascular dysfunction,
hypoxia and oxidative stress play critical roles. Prostacyclin release
during cordocentesis is decreased in pregnancies complicated by
IUGR (Rizzo et al., 1996). Elevated levels of ET-1 were found in
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samples of umbilical venous blood obtained from IUGR preg-
nancies with abnormal Doppler waveforms (Erdem et al., 2003)
and the villous core receptors for ET-1 appear to be functional.
On the other hand, nitric oxide is the main vasodilator of the
uteroplacental blood ﬂow and it has also been suggested that inhi-
bition of its synthesis reduces basal perfusion and increases ﬂow
resistance (Myatt et al., 1997; Parra et al., 2001). However, it has
beenpostulated that themarkedhypoxic vasoconstrictive response
in pathological pregnancies is mediated by inhibition of potas-
sium channels in small intraplacental vessels (Hampl et al., 2002).
Hypoxemic growth-restricted fetuses also show a whole range
of haematological abnormalities, including erythroblastemia and
thrombocytopenia. Hypoxia is a trigger for erythropoietin release
and stimulation of red blood cell production, through both
medullary and extramedullary sites, resulting in polycythemia
(Pallotto and Kilbride, 2006). Furthermore, there is a reduc-
tion in platelet count which inversely correlates with umbilical
artery Doppler, and can be explained by placental consumption or
dysfunctional erythropoiesis and thrombopoiesis (Baschat et al.,
2013).
In IUGR pregnancies, histological studies have shown that the
process of spiral artery vascular transformation is incomplete. In
a normal pregnancy, the luminal diameter of the spiral arter-
ies is greatly enlarged, and the walls are remodeled such that
they contain very little smooth muscle. These changes extend
into the vessels to the inner third of the myometrium to pro-
vide a low-resistance circuit for perfusion of the intervillous space.
These modiﬁcations are associated with endovascular invasion
of the fetal trophoblast into these maternal vessels. In women
with IUGR, endovascular invasion and spiral artery remodel-
ing occur either very superﬁcially or they do not occur, being
associated with high resistance to ﬂow in the maternal uter-
ine arteries and relative placental hypoperfusion (Brosens et al.,
2011; Everett and Lees, 2012). Increased impedance in the fetal
umbilical arteries becomes evident only when at least 60% of
the placental vascular bed is obliterated (Chaddha et al., 2004).
In pregnancies with IUGR, those with absent end-diastolic fre-
quencies, compared to those with normal Doppler, have more
fetal stem vessels with medial hyperplasia and luminal oblitera-
tion, and those with reversed end-diastolic ﬂow have more poorly
vascularized terminal villi, villous stromal haemorrhage, “haem-
orrhagic endovasculitis,” and abnormally thin-walled fetal stem
vessels (Salaﬁa et al., 1997). Absent/reversed end diastolic ﬂow
in umbilical artery represents the extreme end of the spectrum
and this ﬁnding is associated with a high perinatal mortality,
particularly after 30 weeks of pregnancy (Parra-Saavedra et al.,
2014).
In fetal hypoxemia there is an increase in the blood supply to
the brain and reduction in the perfusion of the kidneys, gastro-
intestinal tract and the lower extremities (the so-called brain
sparing effect; Baschat, 2004). Although knowledge of the fac-
tors governing circulatory readjustments and their mechanism
of action is incomplete, it appears that partial pressures of oxy-
gen and carbon dioxide play a role, presumably through their
action on chemoreceptors. This mechanism allows preferential
delivery of nutrients and oxygen to vital organs, thereby com-
pensating for diminished placental resources (Vyas et al., 1990).
On the other hand, the hemodynamic changes occurring in fetal
arterial vessels during hypoxaemia and acidaemia induced by
uteroplacental insufﬁciency are vasoconstriction, expressing as
increased impedance to ﬂow in descending aorta and renal artery
(Grifﬁn et al., 1984). Therefore, as a consequence of the brain
sparing condition, there are selective modiﬁcations in cardiac
afterload with a decreased left ventricle afterload due to cere-
bral vasodilatation, and an increased right ventricle afterload due
to the systemic and pulmonary vasoconstriction (Groenenberg
et al., 1989). Furthermore, hypoxemia may impair myocardial
contractility while the polycythemia, which is usually present,
may alter blood viscosity and therefore preload (Soothill et al.,
1987). Alterations in fetal venous circulation will manifest an
increase of reverse ﬂow in the inferior vena cava during atrial
contraction, and progressive fetal deterioration, suggesting a
higher pressure gradient in the right atrium (Hecher and Hack-
elöer, 1997). The next stage of this disease is the extension of
these abnormal blood velocities to the ductus venosus, rising
systolic pressure and reducing diastolic ﬁlling as an expression
of myocardiac dysfunction (Baschat, 2004). Finally the high
venous pressure induces a reduction of velocity at the end
of diastole in the umbilical vein, causing typical end diastolic
pulsations (Rizzo et al., 1995). The epilogue of these clinical cir-
cumstances is cardiovascular impairment and umbilico-placental
dysfunction.
CONCLUSION
The full understanding of the umbilico-placental vascular func-
tions will have important implications in developing therapies
for oxidative-stress and hypoxia complicated pregnancies. Oxida-
tive stress in chronic hypoxic conditions during gestation arises
in multiple organ systems and subcellular compartments. This
occurs due to an imbalance between cellular pro-oxidant and/or
anti-oxidant detoxifying mechanisms. The umbilico-placental
vasculature during pregnancy seems to be particularly affected
as highly sensitive territories to changes in levels of oxygen and
reactive oxygen species. Although these aspects have suggested
the rationale for antioxidant therapy during pregnancy, still there
are no effective treatments. Several randomized controlled trials
have been performed to determine whether antioxidants supple-
mentation in complicated pregnancies are beneﬁcial, showing
no evidence that these supplements may prevent preeclamp-
sia (Poston et al., 2006, 2011; Basaran et al., 2010; Roberts
et al., 2010; Xu et al., 2010; Conde-Agudelo et al., 2011; Kalpdev
et al., 2011; Rumbold et al., 2011; Polyzos et al., 2012). In
marked contrast, animal models and few human experiences
have shown effectiveness in the use of different antioxidants
preventing pregnancy complications and short- and long-term
vascular dysfunction during pathologic pregnancies (Richter et al.,
2009; Tara et al., 2010; Parraguez et al., 2011; Giussani et al.,
2012; Wibowo et al., 2012; Jones et al., 2013; Kane et al., 2013).
Nowadays, it is not recommended the use of antioxidants in
pregnancy but the debate is still open and it merits new ther-
apeutical approaches as it is clear that oxidative stress is partly
determining complications. Further research on umbilical and
placental vascular function under stressed conditions is still
required.
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